Search Results - "Georgakis, Georgios V."
-
1
Design and radiosynthesis of class-IIa HDAC inhibitor with high molar activity via repositioning the 18F-radiolabel
Published in Scientific reports (02-07-2024)“…The design and radiosynthesis of [ 18 F]NT376, a high potency inhibitor of class-IIa histone deacetylases (HDAC) is reported. We utilized a three-step…”
Get full text
Journal Article -
2
Development of a Radiolabeled Cyclin-Dependent Kinases 4 and 6 (CDK4/6) Inhibitor for Brain and Cancer PET Imaging
Published in International journal of molecular sciences (01-07-2024)“…The synthesis, biochemical evaluation and radiosynthesis of a cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitor and radioligand was performed. NT431, a newly…”
Get full text
Journal Article -
3
Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues
Published in Annals of surgical oncology (01-09-2018)“…Background Organoids are three-dimensional in vitro models of human disease developed from benign and malignant gastrointestinal tissues with tremendous…”
Get full text
Journal Article -
4
Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines
Published in Blood (15-08-2008)“…Epigenetic changes have been implicated in silencing several B-cell genes in Hodgkin and Reed-Sternberg cells (HRS) of Hodgkin lymphoma (HL), and this…”
Get full text
Journal Article -
5
Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL‐R1 and TRAIL‐R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin‐ and bortezomib‐induced cell death
Published in British journal of haematology (01-08-2005)“…Summary Tumour necrosis factor‐related apoptosis‐inducing ligand (TRAIL/Apo2L) is a death protein that preferentially kills tumour cells while sparing normal…”
Get full text
Journal Article -
6
Inhibition of Heat Shock Protein 90 Function by 17-Allylamino-17-Demethoxy-Geldanamycin in Hodgkin's Lymphoma Cells Down-Regulates Akt Kinase, Dephosphorylates Extracellular Signal–Regulated Kinase, and Induces Cell Cycle Arrest and Cell Death
Published in Clinical cancer research (15-01-2006)“…Purpose: Heat shock protein 90 (HSP90) is a chaperone for several client proteins involved in transcriptional regulation, signal transduction, and cell cycle…”
Get full text
Journal Article -
7
The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells
Published in Blood (01-08-2008)“…B-cell chronic lymphocytic leukemia (B-CLL) is a lymphoproliferative disorder characterized by the surface expression of CD20, CD5 antigens, as well as the…”
Get full text
Journal Article -
8
Inhibition of the phosphatidylinositol‐3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma
Published in British journal of haematology (01-02-2006)“…Summary Activation of the phosphatidylinositol 3‐kinase (PI3K) pathway has been linked with tumour cell growth, survival and resistance to therapy in several…”
Get full text
Journal Article -
9
Induction of Cell Cycle Arrest and Apoptosis by the Proteasome Inhibitor PS-341 in Hodgkin Disease Cell Lines Is Independent of Inhibitor of Nuclear Factor-κB Mutations or Activation of the CD30, CD40, and RANK Receptors
Published in Clinical cancer research (01-05-2004)“…Purpose: The malignant Hodgkin and Reed-Sternberg cells of Hodgkin disease (HD) are known to constitutively express high levels of activated nuclear factor κB…”
Get full text
Journal Article -
10
Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer
Published in British journal of cancer (08-01-2019)“…Background Pancreatic cancer (PC) hijacks innate cellular processes to promote cancer growth. We hypothesized that PC exploits PD-1/PD-L1 not only to avoid…”
Get full text
Journal Article -
11
-
12
A Multicenter Phase 1 Trial Evaluating Nanoliposomal Irinotecan for Heated Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery for Patients with Peritoneal Surface Disease
Published in Annals of surgical oncology (01-02-2023)“…Background Nanoliposomal irinotecan (nal-IRI) is a promising novel hyperthermic intraperitoneal chemotherapy (HIPEC) agent given its enhanced efficacy against…”
Get full text
Journal Article -
13
Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma
Published in Experimental hematology (01-04-2008)“…Objective To investigate the mechanisms of antiproliferative effect induced by the mammalian target of rapamycin (mTOR) inhibitor temsirolimus in mantle cell…”
Get full text
Journal Article -
14
Correction: Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer
Published in British journal of cancer (01-08-2020)“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text
Journal Article -
15
Prognostic significance of serum B-lymphocyte stimulator level in Hodgkin's lymphoma
Published in Haematologica (Roma) (01-02-2007)“…Department of Lymphoma and Myeloma, The University of Texas, M. D. Anderson Cancer Center, Houston, TX, 77030 and Department of Clinical Immunoassays, Human…”
Get full text
Journal Article -
16
The heat shock protein 90 inhibitor 17‐AAG induces cell cycle arrest and apoptosis in mantle cell lymphoma cell lines by depleting cyclin D1, Akt, Bid and activating caspase 9
Published in British journal of haematology (01-10-2006)“…Summary Mantle cell lymphoma (MCL), a distinct type of non‐Hodgkin lymphoma, is characterised by the overexpression of cyclin D1. Heat shock protein 90 (HSP90)…”
Get full text
Journal Article -
17
Case report of intestinal non-rotation, heterotaxy, and polysplenia in a patient with pancreatic cancer
Published in Medicine (Baltimore) (01-12-2017)“…Heterotaxy with polysplenia is an extremely rare congenital condition resulting from abnormal arrangement of organs in the abdominal and thoracic cavities…”
Get full text
Journal Article -
18
From Rapa Nui to rapamycin: targeting PI3K/Akt/mTOR for cancer therapy
Published in Expert review of anticancer therapy (01-01-2006)“…One of the most prominent pathways explored in the area of targeted therapy is the PI3K/Akt/mTOR pathway, which plays a central role in cell survival and…”
Get full text
Journal Article -
19
Heat-shock protein 90 inhibitors in cancer therapy: 17AAG and beyond
Published in Future oncology (London, England) (01-04-2005)“…Heat-shock protein 90 (HSP90) has diverse functions in mammalian cells. It acts as molecular chaperone, together with several co-chaperone molecules (such as…”
Get more information
Journal Article -
20
The HSP90 inhibitor 17-AAG synergizes with doxorubicin and U0126 in anaplastic large cell lymphoma irrespective of ALK expression
Published in Experimental hematology (01-12-2006)“…Heat shock protein 90 (HSP90) chaperones and maintains the molecular integrity of a variety of signal transduction proteins, including the…”
Get full text
Journal Article